The global intellectual property ecosystem for insulin and its public health implications: an observational study by Warren A. Kaplan, Reed F. Beall

Get full text

In which developing countries are patents on essential medicines being filed? by Reed F Beall, Rosanne Blanchet, Amir Attaran

Get full text

The private versus public contribution to the biomedical literature during the COVID-19, Ebola, H1N1, and Zika public health emergencies by Reed F. Beall, Javad Moradpour, Aidan Hollis

Get full text

Repurposing existing drugs for new uses: a cohort study of the frequency of FDA-granted new indication exclusivities since 1997 by Babak Sahragardjoonegani, Reed F. Beall, Aaron S. Kesselheim, Aidan Hollis

Get full text

The timing of 30‐month stay expirations and generic entry: A cohort study of first generics, 2013–2020 by Sunand Kannappan, Jonathan J. Darrow, Aaron S. Kesselheim, Reed F. Beall

Get full text

Patents and regulatory exclusivities on FDA-approved insulin products: A longitudinal database study, 1986–2019 by Anders Olsen, Reed F. Beall, Ryan P. Knox, Sean S. Tu, Aaron S. Kesselheim, William B. Feldman

Get full text

Patents and regulatory exclusivities on FDA-approved insulin products: A longitudinal database study, 1986-2019. by Anders Olsen, Reed F Beall, Ryan P Knox, Sean S Tu, Aaron S Kesselheim, William B Feldman

Get full text

Laboratory testing and antihypertensive medication adherence following initial treatment of incident, uncomplicated hypertension: A real‐world data analysis by Reed F. Beall, Alexander A. Leung, Amity E. Quinn, Charleen Salmon MD, MSc, Tayler D. Scory, Lauren C. Bresee, Paul E. Ronksley

Get full text

Exploring the prospective acceptability of a healthy food incentive program from the perspective of people with type 2 diabetes and experiences of household food insecurity in Albe... by Saania Tariq, Dana Lee Olstad, Reed F Beall, Eldon Spackman, Lorraine Lipscombe, Sharlette Dunn, Bonnie M Lashewicz, Meghan J Elliott, David JT Campbell

Get full text